DEBRA PAINTER: Open Payments
NPI 1952877144 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 39 payments from 14 companies in 2025. Trend: 2023 $354 · 2024 $422 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 10 | $150 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Axsome Therapeutics, Inc. | 3 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| ABBVIE INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
Products named: SUBLOCADE, Auvelity, CAPLYTA, BREZTRI, REXULTI, Kerendia, FANAPT, QULIPTA.
Industry payments across IN — which companies pay providers there.
